Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

DSpace Repository

Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Author: Wagner, Nikolaus B.; Lenders, Max M.; Kuehl, Kathrin; Reinhardt, Lydia; Fuchss, Milena; Ring, Natalie; Staeger, Ramon; Zellweger, Caroline; Ebel, Chiara; Kimeswenger, Susanne; Oellinger, Angela; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Klumpp, Bernhard; Hoetzenecker, Wolfram; Terheyden, Patrick; Mangana, Joanna; Loquai, Carmen; Cozzio, Antonio; Garbe, Claus; Meier, Friedegund; Eigentler, Thomas K.; Flatz, Lukas
Tübinger Autor(en):
Wagner, Nikolaus B.
Amaral, Teresa
Klumpp, Bernhard
Garbe, Claus
Flatz, Lukas
Lenders, Max Matthias
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Eigentler, Thomas
Published in: European Journal of Cancer (2024), Bd. 196, Article 113425
Verlagsangabe: London : Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2023.113425
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)